FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

326120003: Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3695852016 Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3695854015 Dinoprostone 800 microgram/mL vaginal gel en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) Is a Dinoprostone-containing product in vaginal dose form false Inferred relationship Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Prostaglandin PGE>2< false Inferred relationship Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Prostaglandin E>1< false Inferred relationship Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dinoprostone (substance) false Inferred relationship Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Posterior pituitary hormone false Inferred relationship Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Alprostadil false Inferred relationship Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) Has manufactured dose form Vaginal dose form (dose form) false Inferred relationship Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) Has manufactured dose form Vaginal gel true Inferred relationship Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Dinoprostone (substance) true Inferred relationship Some 1
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) Has concentration strength denominator value un false Inferred relationship Some 1
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. mcg true Inferred relationship Some 1
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Dinoprostone (substance) true Inferred relationship Some 1
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) Has concentration strength numerator value 800 false Inferred relationship Some 1
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) Count of base of active ingredient un false Inferred relationship Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 1
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) Is a Dinoprostone only product in vaginal dose form true Inferred relationship Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) Plays role Oxytocic therapeutic role (role) false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start